International Consensus Document – Cellular, Acellular and Matrix-Like Products (CAMPS) in Pressure Injuries

Overview

This consensus document explores the issue and prevalence of pressure injuries, emphasizing the essential role of CAMPs and other emerging treatment strategies in their management. Among these approaches, topical oxygen therapy is highlighted as a key consideration in promoting wound healing.

Main Points in this Publication that relate to NATROX® O₂ / Topical Oxygen Therapy

• PIs have a high prevalence and incidence and need new treatment strategies.
• Cellular, acellular and matrix-like products (CAMPs) are advanced wound-care tools that promote innate healing processes, such as stimulating fibroblast activity, granulation tissue formation, and keratinocyte migration.
• Application of CAMPs must be preceded by wound-bed preparation encompassing tissue debridement, inflammation/infection control, moisture management, and optimization of patient and social factors.
• Biorburden, inflammation, and infection can be controlled with products, such as topical oxygen therapy
• Wounds may require regenerative interventions to promote repair, such as topical oxygen therapy and CAMPs.
• Holistic care goals such as better quality of life, fewer hospitalizations, pain reduction, reduced caretaker burden need to be included in treatment plans. This should encourage the use of advanced therapies, including topical oxygen  and CAMPs.